Also trades as: EMMAW (OTC) · $vol 0M
EMMA OTC
Emmaus Life Sciences, Inc.
1W: -18.9%
1M: -22.5%
3M: +381.6%
YTD: +323.1%
1Y: +423.8%
3Y: -72.3%
5Y: -96.3%
$0.06
-0.01 (-15.38%)
Weekly Expected Move ±26.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-12-31
Earliest Filing
2026-03-04
Latest Filing
partner: 2
Counterparties (Filed by EMMA)
2 relationshipsCompanies named in EMMA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| NeoImmuneTech, Inc. | 950220.KQ | partner | Partnered with Emmaus Life Sciences for an exclusive license and supply agreement to market and distribute Endari in the | 2026-03-04 | View |
| NeoImmuneTech, Inc. | 950220.KQ | partner | Entered into a License and Exclusive Distribution Agreement for Endari in sickle cell disease markets in the U.S. and Ca | 2025-12-31 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-04-17 | Officer/Director Change; Exhibits | View | |
| 2026-04-14 | Officer/Director Change; Exhibits | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-03-04 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-31 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-12-22 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-12-19 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-01 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-06 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-04-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-10-25 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2024-10-04 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-09-10 | Results of Operations and Financial Condition; Changes in Registrant's Certifying Accountant; Financ | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR